U.S. regulators have sent warning letters to dozens of retailers selling fruity disposable e-cigarettes, including the current best-selling brand, Elf Bar
FILE - The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed on Oct. 14, 2015. The FDA on Thursday, June 22, 2023, said it has sent warning letters to dozens of retailers selling fruit- and candy-flavored disposable e-cigarettes, including the current best-selling brand, Elf Bar. It’s the latest attempt by regulators to crack down on illegal disposable vapes that have poured into U.S. stores in recent years.
In the latest action, the FDA said it issued warnings to 189 convenience stories, vape shops and other retailers. The rise coincided with the growing popularity of disposable e-cigarettes. The analysis showed disposables’ share of vaping sales more than doubled from 24.7% in early 2020 to nearly 52% by late last year.
The FDA and CDC also cited Elf Bar in a separate report about thousands of calls to U.S. poison centers concerning e-cigarettes, mainly involving children under age 5. Despite the missing data, FDA's King called the high number of reports involving Elf Bar a “canary in the coal mine.”
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
New Austin bar 'Sign Bar' now open featuring 75+ signs from legendary local businessesFeeling a little nostalgic? A new Austin bar displaying over 75 classic signs from legendary local businesses across the city is now open.
続きを読む »
“Secret Garden bar in Dupont Circle” - PoPvillecourtesy Hank’s Oyster Bar From an email: 'a new outdoor alley bar at woman-owned Hank’s Oyster Bar. Q Street Secret Garden Bar: Hank’s Oyster Bar’s new secret garden bar, Q Street, at the Dupont Circle location. Head down the alley between Fox & Hound and Agora and emerge into this secret garden oasis that’s open
続きを読む »
FDA Warns of Tattoo Ink Tied to Dangerous InfectionsThe FDA released the new draft guidance aiming to reduce the use of pathogen-contaminated tattoo ink, which can cause stubborn infections that are especially hard to treat, dermatologists said.
続きを読む »
FDA OKs Drug for Cholestatic Pruritus in Alagille SyndromeOdevixibat is indicated for treatment of cholestatic pruritus associated with Alagille syndrome in patients as young as 12 months. It marks the second indication for the drug.
続きを読む »
FDA OKs Low-Dose Colchicine for Broad CV IndicationThe drug represents the first specific anti-inflammatory drug for the reduction of cardiovascular events for patients with established atherosclerotic disease or with multiple risk factors.
続きを読む »
FDA OKs Empagliflozin for Children With Type 2 DiabetesThe FDA has approved empagliflozin and empagliflozin combined with metformin for the treatment of type 2 diabetes in children aged 10 years and older.
続きを読む »